Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02303561 · ClinicalTrials.gov registry record · NA

The Childhood Health and Asthma Management Program

A NA study of Obesity and Asthma, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT02303561: Completed NA study of Obesity and Asthma, sponsored by University of Florida.

NCT02303561 is a NA study of Obesity and Asthma that has completed, run by University of Florida. The registered enrollment target is 56 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02303561, a NA study of Obesity and Asthma, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

Overweight and obese (OV/OB) children with asthma are at-risk for particularly poor health outcomes including poor asthma control, higher risk of asthma-related symptoms, and decreased quality of life. Weight loss reduces asthma symptoms, improves lung function, and increases quality of life among OV/OB adults with asthma. Little research has examined the impact of weight loss on asthma outcomes in OV/OB youth, and there is little research examining weight management interventions in OV/OB children with asthma. Behavioral family-based lifestyle interventions are successful in producing weight loss in children. To our knowledge, however, there has been no systematic effort to examine the impact of these interventions on weight status and asthma outcomes, nor has there been an effort to tailor these programs to the specific needs of OV/OB children with asthma. The aims of this study are to develop and test the Childhood Health and Asthma Management Program (CHAMP), a behavioral family-based lifestyle intervention that is community-based to promote successful weight and asthma management in OV/OB children with asthma. The investigators propose to develop an intervention based on a previously developed behavioral family-based lifestyle intervention that was community-based and produced positive long term weight status changes in OV/OB children and tailor it for OV/OB children with asthma to create CHAMP. CHAMP will include asthma education and targeting unique barriers to weight management in OV/OB children with asthma. A focus group will be conducted with OV/OB children with asthma, ages 6-12, and their parent(s). Then a pilot randomized controlled trial of the CHAMP intervention with 32 OV/OB children with asthma, ages 6-12 years, and their parent(s). Families will be randomly assigned to CHAMP or a health education group. The investigators hypothesize that participants in CHAMP will have more effective weight and asthma management and child asthma outcomes compared

Interventions

  • BEHAVIORAL Health education
  • BEHAVIORAL CHAMP

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2014-06
Est. Completion 2017-03-13
Phase NA
University of Florida

1,106 total trials

What the finished NCT02303561 record still lists

NCT02303561 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower).

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Health education is the first listed.

NCT02303561 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT02303561 about?

NCT02303561 is a clinical study titled "The Childhood Health and Asthma Management Program". Overweight and obese (OV/OB) children with asthma are at-risk for particularly poor health outcomes including poor asthma control, higher risk of asthma-related symptoms, and decreased quality of life. Weight loss reduces asthma symptoms, improves lung function, and increases quality of life among O...

What is the current status of trial NCT02303561?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2014-06. Estimated completion is 2017-03-13.

What conditions does trial NCT02303561 study?

This clinical trial studies the following conditions: Obesity, Asthma, Family, Child.

What interventions are being tested in trial NCT02303561?

The interventions under investigation include: Health education (BEHAVIORAL), CHAMP (BEHAVIORAL).

Who is sponsoring clinical trial NCT02303561?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02303561 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02303561's enrollment target sits among peer trials

56 689th of 1053 higher than 360 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02303561, the US trial registry maintained by the National Library of Medicine. NCT02303561 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.